Loading your page…
Each register with its number of medicines and a few of them.
FDA · 2 medicines
AEMPS · 1 medicine
EMA · 1 medicine
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
HALMED · 1 medicine
CBG-MEB · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
9 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| ANGIOTENSIN ll ACETATE | United States | 2.5MG BASE/ML | solution | Marketed | Gland |
| Giapreza | United States | 0.5MG BASE/ML, 2.5MG BASE/ML, 5MG BASE/2ML | solution | Marketed | LA Jolla Pharma |
| Giapreza | European Union | Authorised | Paion Pharma GmbH | ||
| Giapreza 2,5 MG/ML Concentrado Para Solucion Para Perfusion | Spain | 2,5 mg/ml | concentrado para solución para perfusión | Marketed | Paion Pharma Gmbh |
| Giapreza 2,5 mg/ml concentraat voor oplossing voor infusie | Netherlands | Concentraat voor oplossing voor infusie | Authorised | Paion Pharma GmbH | |
| Giapreza | Italy | Concentrato per soluzione per infusione | Authorised | Paion Pharma GMBH | |
| Giapreza | Croatia | Marketed | |||
| Angio II | Brazil | Cancelled | Medley Indústria Farmacêutica Ltda | ||
| Angio II | Brazil | Cancelled | Sanofi Medley Farmacêutica Ltda. |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, CBG-MEB, EMA, FDA and HALMED. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
